Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marniza Saad

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Lancet Regional Health. Western Pacific|July 23, 2025
Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline <i>APOBEC3B</i> deletion: results of the phase II AUROR studyGwo Fuang Ho, Soo Chin Lee, Anita Zarina Bustam, et al.
Asia-Pacific Journal of Clinical Oncology|March 2, 2026
Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025Edmund Chiong, Renu Eapen, Nicholas Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Lancet Regional Health. Western Pacific|July 23, 2025
Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline <i>APOBEC3B</i> deletion: results of the phase II AUROR studyGwo Fuang Ho, Soo Chin Lee, Anita Zarina Bustam, et al.
Asia-Pacific Journal of Clinical Oncology|March 2, 2026
Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025Edmund Chiong, Renu Eapen, Nicholas Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|February 8, 2022
Managing advanced prostate cancer in the Asia Pacific region: "Real-world" application of Advanced Prostate Cancer Consensus Conference 2019 statementsEdmund Chiong, Declan G Murphy, Nicholas C Buchan, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
Management of advanced prostate cancer in the Asia-Pacific region: Summary of the Asia-Pacific Advanced Prostate Cancer Consensus Conference 2023Edmund Chiong, Declan G Murphy, Nicholas Buchan, et al.
Pageof 5